Participant Database for Autism Research Studies

Autism Spectrum Disorder Clinical Trial

Official title:

Database for Persons Interested in Research Studies of Developmental Disorders

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00549731
• Other study ID #: 2007-P-000062
• Secondary ID: 5R01MH117998
• Status: Recruiting
• Start date: June 2013
• Est. completion date: June 2023

Study information

• Verified date: September 2020
• Source: Massachusetts General Hospital
• Contact: Nicole McGuiggan, Rsch Coord
• Phone: 617-966-9766
• Email: TRANSCEND[@]partners.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.

Description:

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities

Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group

Aim 3: to maintain subject information in a database, from which we can recruit for our studies

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: June 2023
• Est. primary completion date: June 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 14 Years to 32 Years

Eligibility

Inclusion Criteria:

• Typically-developing, healthy adolescents and adults (ages 14-32)

• Adolescents and adults with autism spectrum disorder (ages 14-32)

Exclusion Criteria:

• Extreme premature birth (<34 weeks)

• Known genetic disorders related to autism (e.g. Fragile X)

• Recent diagnosis of psychosis (within 6 months)

• Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome).

• Metal implants / permanent retainers / hair dyes with metallic components

Related Conditions & MeSH terms

• Autism Spectrum Disorder
• Autistic Disorder

Locations

Country	Name	City	State
United States	Martinos Center of Biomedical Imaging	Charlestown	Massachusetts

Sponsors (3)

Lead Sponsor	Collaborator
Massachusetts General Hospital	National Institute of Mental Health (NIMH), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States,